Atlas Trials

Allogeneic UCB-derived CAR-T for B-ALL

Clinical trial NCT07256353 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07256353
Sponsor
The General Hospital of Western Theater Command
Status
NOT_YET_RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
B-Cell Acute Lymphoblastic Leukemia, Adult
Start date
2025-12-01
Primary completion
2030-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.